Boston Scientific to pay out $195 million to settle Guidant product lawsuits

19 July 2007

Natick, Mass., USA. Boston Scientific Corporation (NYSE:BSX) has announced that an agreement has been reached to settle lawsuits from 2005 and 2006 associated with cardiac products manufactured by Guidant Corporation. Boston Scientific acquired Guidant Corporation in 2006.

Under the terms of the agreement, subject to certain conditions, Boston Scientific will pay a total of $195 million. The agreement includes approximately 4,000 claims of individuals that have been consolidated in the US District Court for the District of Minnesota in a Multi-District Litigation (MDL).

In addition, the agreement includes an undetermined number — but not all — of additional similar claims throughout the country. As a result of the agreement, the trials in the bellwether cases in the MDL scheduled to start on July 30 have been suspended pending implementation of the agreement.

"We are pleased by this resolution, which is in the best interest of all involved," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "It will better allow us to focus our time and resources on developing innovative products to serve physicians and patients."

To top

Save this page on

To top